Tiziana Life Sciences Ltd

Market Cap

$178M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$1.24-$0.36 (-22.50%)

Jun 5, 2026

52W High $2.5052W Low $1.15

Company Details

Tiziana Life Sciences Ltd, a biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-4...

CEO

—

IPO Date

Mar 24, 2000

Website

www.tizianalifesciences.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$35M

EPS (Diluted)

Free Cash Flow

-$16M

Revenue / Share

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 1, 2026

FY 2025

May 1, 2026

Q2 2025

Jun 30, 2025

Q1 2025

May 6, 2025

FY 2024

May 6, 2025

Revenue & Profitability

Operating Cash Flow

CapEx Spend

Stock-Based Compensation

OpEx Breakdown

War Chest (GBP)

Shares Outstanding